Index of reports
> Cases with Neutropenia (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytoxan (Cyclophosphamide) where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cytoxan side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: female
Reactions: Pneumocystis Jiroveci Pneumonia, Maternal Exposure During Pregnancy, Neutropenia, Premature Labour
Drug(s) suspected as cause:
Adriamycin PFS
Indication: Breast Cancer Stage II
Paclitaxel
Indication: Breast Cancer Stage II
Cytoxan
Indication: Breast Cancer Stage II
Possible Cytoxan side effects in female
Reported by a physician from Italy on 2012-06-06
Patient: female, weighing 45.5 kg (100.1 pounds)
Reactions: Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased, Streptococcal Infection, Pneumonitis, Hypertransaminasaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisolone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
End date: 2011-11-18
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
Cytoxan
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
Possible Cytoxan side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-30
Patient: female
Reactions: Pneumonia, Neutropenia
Drug(s) suspected as cause:
Epirubicin Hydrochloride
Dosage: unk
Cytoxan
Dosage: unk
Possible Cytoxan side effects in 12 year old female
Reported by a physician from Argentina on 2012-05-25
Patient: 12 year old female
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Cytoxan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Possible Cytoxan side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-24
Patient:
Reactions: Neuropathy Peripheral, Neutropenia, Infusion Related Reaction, Infection
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 6-821 day cycles; n=28
Vincristine
Indication: B-Cell Lymphoma
Doxorubicin HCL
Dosage: 6-821 day cycles; n=28
Indication: B-Cell Lymphoma
Obinutuzumab
Indication: B-Cell Lymphoma
Cytoxan
Indication: B-Cell Lymphoma
Prednisone
Indication: B-Cell Lymphoma
Possible Cytoxan side effects in male
Reported by a physician from Germany on 2012-05-22
Patient: male
Reactions: Febrile Neutropenia, Skin Infection, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-06
End date: 2012-04-20
Acyclovir
Dosage: 400 mg, unk
Administration route: Oral
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Cytoxan
Dosage: 1500 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-17
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-02-02
End date: 2012-04-21
Rituximab
Dosage: 750 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-02-01
End date: 2012-04-16
Other drugs received by patient: Acyclovir; Paspertin / 00041902 /; Metoclopramide; Rulid; Pantoprazole; Electrolytes NOS W / Macrogol 3350; Dipyrone TAB; MST / 00036302 /; Novalgin / 00169801 /
Possible Cytoxan side effects in male
Reported by a physician from Germany on 2012-05-18
Patient: male
Reactions: Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Cytoxan
Dosage: 1600 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-17
End date: 2012-04-17
Neulasta
Dosage: 6 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-20
End date: 2012-04-20
Rituximab
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-16
Prednisolone
Dosage: 50 mg, bid
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-16
End date: 2012-04-21
Other drugs received by patient: Metoclopramide; Acyclovir; Pantoprazole; Dipyrone TAB; Morphine Sulfate
Possible Cytoxan side effects in 74 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26
Patient: 74 year old male, weighing 81.2 kg (178.6 pounds)
Reactions: Excoriation, Anaemia, Hypotension, Neutropenic Sepsis, Tachycardia, Mental Status Changes, Atrial Fibrillation, Pyrexia, Fall, Cardiac Failure, Diarrhoea, Neutropenia, Cardiac Arrest, Lethargy, Cough
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisone
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-15
Lasix
Indication: Cardiac Disorder
End date: 2012-02-22
Matulane
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-15
Spironolactone
Indication: Cardiac Disorder
End date: 2012-02-22
Coreg
Indication: Cardiac Disorder
End date: 2012-02-22
Cytoxan
Start date: 2012-02-09
End date: 2012-02-16
Lisinopril
Indication: Cardiac Disorder
End date: 2012-02-22
Vinblastine Sulfate
Start date: 2012-02-09
End date: 2012-02-16
Other drugs received by patient: Levofloxacin; Prevacid; Tamsulosin HCL; Klor-CON; Folic Acid; Multi-Vitamins; Bleomycin Sulfate; Dacarbazine; Lidocaine; Zofran; Doxorubicin HCL
Possible Cytoxan side effects in 48 year old female
Reported by a physician from United States on 2011-10-28
Patient: 48 year old female
Reactions: Renal Failure, Nausea, Mouth Ulceration, Anaemia, Squamous Cell Carcinoma of Skin, Neutropenia, Rash, Accidental Exposure
Drug(s) suspected as cause:
Dapsone
Dosage: titrated up to 100 mg twice daily, titrated up to 50 mg daily
Indication: Behcet's Syndrome
Arava
Dosage: 20 mg daily
Indication: Behcet's Syndrome
Imuran
Dosage: titrated up to 150 mg daily
Indication: Behcet's Syndrome
Plaquenil
Dosage: 300 mg daily, 200 mg daily, 200 mg twice daily, oral
Administration route: Oral
Indication: Behcet's Syndrome
Enbrel
Dosage: 25 mg twice weekly
Indication: Behcet's Syndrome
Methotrexate
Dosage: 7.5 mg per week, titrated up to 20 mg per week
Indication: Behcet's Syndrome
Cytoxan
Dosage: 250 mg, 250 mg, 500 mg, 750 mg, 1000 mg, 1250 mg, intravenous
Indication: Behcet's Syndrome
Cyclosporine
Indication: Behcet's Syndrome
End date: 2001-01-06
Remicade
Dosage: 200 mg, 300 mg, 400 mg, intravenous
Indication: Behcet's Syndrome
Leukeran
Dosage: titrated up to 4 mg daily, 3 mg daily, 3 mg daily
Indication: Behcet's Syndrome
Colchicine
Dosage: 6 mg twice daily, 6 mg twice daily
Indication: Behcet's Syndrome
Cellcept
Dosage: 1000 mg twice daily
Indication: Behcet's Syndrome
Rituxan
Dosage: 1000 mg, 1000 mg, intravenous
Indication: Behcet's Syndrome
End date: 2006-07-05
Prednisone
Dosage: 10 mg daily
Indication: Behcet's Syndrome
Other drugs received by patient: Terbutaline Sulfate; (Esomeprazole); Pregabalin; Acyclovir; (Fentanyl); Erythromycin; Sertraline Hydrochloride; Theophylline; Pentoxifylline; Furosemide; Folic Acid; Fluticasone Propionate / Salmeterol; Ipratropium Bromide and Albuterol Sulfate
|